Repositório Científico do Instituto Nacional de Saúde >
Departamento de Genética Humana >
DGH - Artigos em revistas internacionais >
Please use this identifier to cite or link to this item:
|Título: ||Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).|
|Autor: ||Schleiermacher, G.|
de Lacerda, A.
de Bernardi, B.
di Cataldo, A.
van Roy, N.
|Palavras-chave: ||Doenças Genéticas|
Segmental Chromosome Alterations
|Issue Date: ||Dec-2011|
|Editora: ||Nature Publishing Group|
|Citação: ||Br J Cancer. 2011 Dec 6;105(12):1940-8. Epub 2011 Nov 10|
|Resumo: ||BACKGROUND: In neuroblastoma (NB), the presence of segmental chromosome alterations (SCAs) is associated with a higher risk of relapse.
METHODS: In order to analyse the role of SCAs in infants with localised unresectable/disseminated NB without MYCN amplification, we have performed an array CGH analysis of tumours from infants enrolled in the prospective European INES trials.
RESULTS: Tumour samples from 218 out of 300 enroled patients could be analysed. Segmental chromosome alterations were observed in 11%, 20% and 59% of infants enroled in trials INES99.1 (localised unresectable NB), INES99.2 (stage 4s) and INES99.3 (stage 4) (P<0.0001). Progression-free survival was poorer in patients whose tumours harboured SCA, in the whole population and in trials INES99.1 and INES99.2, in the absence of clinical symptoms (log-rank test, P=0.0001, P=0.04 and P=0.0003, respectively). In multivariate analysis, a SCA genomic profile was the strongest predictor of poorer progression-free survival.
CONCLUSION: In infants with stage 4s MYCN-non-amplified NB, a SCA genomic profile identifies patients who will require upfront treatment even in the absence of other clinical indication for therapy, whereas in infants with localised unresectable NB, a genomic profile characterised by the absence of SCA identifies patients in whom treatment reduction might be possible. These findings will be implemented in a future international trial.|
|Arbitragem científica: ||yes|
|Versão do Editor: ||http://www.nature.com/bjc/journal/v105/n12/full/bjc2011472a.html|
|Appears in Collections:||DGH - Artigos em revistas internacionais|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.